Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhanglin Lin

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Trends in Biotechnology|March 28, 2025
Expediting genome synthesis of Corynebacterium glutamicum with an artificial chromosome vectorZhanhua Zhang, Peixiong Hong, Zebin Li, et al.
Pragmatic and Observational Research|May 21, 2020
Reliability of Conclusions from Early Analyses of Real-World Data for Newly Approved Drugs in Advanced Gastric Cancer in the United StatesLisa M Hess, Michael Grabner, Liya Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2018
Association of quality of life with disease characteristics and treatment outcomes in patients with advanced gastric cancer: Exploratory analysis of RAINBOW and REGARD phase III trialsIan Chau, Charles S Fuchs, Atsushi Ohtsu, et al.
Journal of Patient-Reported Outcomes|December 18, 2024
Time to deterioration of patient-reported outcome endpoints in cancer clinical trials: targeted literature review and best practice recommendationsKim Cocks, Bellinda L King-Kallimanis, Joel Sims, et al.
Systematic Reviews|September 18, 2014
Study protocol: systematic review and meta-analysis of randomized controlled trials in first-line treatment of squamous non-small cell lung cancerAmy M DeLozier, Jacqueline Brown, Fanni Natanegara, et al.
Future Oncology (London, England)|May 25, 2022
A real-world US study of recurrence risks using combined clinicopathological features in HR-positive, HER2-negative early breast cancerKristin M Sheffield, Jessica R Peachey, Michael Method, et al.
Pharmaceutical Statistics|June 10, 2025
Applying Bias Correction Methods to Build Hybrid Controls Using Real-World Patients for a Phase IIb Randomized Controlled Trial of Baricitinib for Rheumatoid ArthritisHeather J Litman, Kristin M Sheffield, Oksana Pugach, et al.
Advances in Therapy|March 30, 2023
Characteristics and Outcomes in Cases of US Male Patients with Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical PracticeAlistair Ring, Meghan Karuturi, Emily Nash Smyth, et al.
Drugs - Real World Outcomes|September 29, 2023
Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2- Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical PracticeAlistair Ring, Meghan Karuturi, Emily Nash Smyth, et al.
Breast Cancer Research and Treatment|June 13, 2023
Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 & 6 inhibitors in patients with HR+, HER2- MBC in the real worldMegan Kruse, Emily Nash Smyth, Lee Bowman, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Trends in Biotechnology|March 28, 2025
Expediting genome synthesis of Corynebacterium glutamicum with an artificial chromosome vectorZhanhua Zhang, Peixiong Hong, Zebin Li, et al.
Pragmatic and Observational Research|May 21, 2020
Reliability of Conclusions from Early Analyses of Real-World Data for Newly Approved Drugs in Advanced Gastric Cancer in the United StatesLisa M Hess, Michael Grabner, Liya Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2018
Association of quality of life with disease characteristics and treatment outcomes in patients with advanced gastric cancer: Exploratory analysis of RAINBOW and REGARD phase III trialsIan Chau, Charles S Fuchs, Atsushi Ohtsu, et al.
Journal of Patient-Reported Outcomes|December 18, 2024
Time to deterioration of patient-reported outcome endpoints in cancer clinical trials: targeted literature review and best practice recommendationsKim Cocks, Bellinda L King-Kallimanis, Joel Sims, et al.
Systematic Reviews|September 18, 2014
Study protocol: systematic review and meta-analysis of randomized controlled trials in first-line treatment of squamous non-small cell lung cancerAmy M DeLozier, Jacqueline Brown, Fanni Natanegara, et al.
Future Oncology (London, England)|May 25, 2022
A real-world US study of recurrence risks using combined clinicopathological features in HR-positive, HER2-negative early breast cancerKristin M Sheffield, Jessica R Peachey, Michael Method, et al.
Pharmaceutical Statistics|June 10, 2025
Applying Bias Correction Methods to Build Hybrid Controls Using Real-World Patients for a Phase IIb Randomized Controlled Trial of Baricitinib for Rheumatoid ArthritisHeather J Litman, Kristin M Sheffield, Oksana Pugach, et al.
Advances in Therapy|March 30, 2023
Characteristics and Outcomes in Cases of US Male Patients with Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical PracticeAlistair Ring, Meghan Karuturi, Emily Nash Smyth, et al.
Drugs - Real World Outcomes|September 29, 2023
Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2- Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical PracticeAlistair Ring, Meghan Karuturi, Emily Nash Smyth, et al.
Breast Cancer Research and Treatment|June 13, 2023
Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 & 6 inhibitors in patients with HR+, HER2- MBC in the real worldMegan Kruse, Emily Nash Smyth, Lee Bowman, et al.
Pageof 11